Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2023-02-21 17:15:33 UTC |
---|
HMDB ID | HMDB0001250 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | N-Acetylarylamine |
---|
Description | N-Acetylarylamine is an odourless solid chemical of leaf or flake-like appearance. It is also known as acetanilide, N-phenylacetamide, acetanil, or acetanilid, and was formerly known by the trade name Antifebrin. N-Acetylarylamine has analgesic and fever-reducing properties; it is in the same class of drugs as acetaminophen (paracetamol). Under the name acetanilid it formerly figured in the formula of a number of patent medicines and over the counter drugs. In 1948, Julius Axelrod and Bernard Brodie discovered that acetanilide is much more toxic in these applications than other drugs, causing methemoglobinemia and ultimately doing damage to the liver and kidneys. As such, acetanilide has largely been replaced by less toxic drugs, in particular acetaminophen, which is a metabolite of acetanilide and whose use Axelrod and Brodie suggested in the same study. |
---|
Structure | InChI=1S/C8H9NO/c1-7(10)9-8-5-3-2-4-6-8/h2-6H,1H3,(H,9,10) |
---|
Synonyms | Value | Source |
---|
Acetamidobenzene | ChEBI | Acetanil | ChEBI | Acetanilid | ChEBI | Acetanilide | ChEBI | Acetic acid anilide | ChEBI | N-Acetylaminobenzene | ChEBI | N-Phenylacetamide | Kegg | Acetate anilide | Generator | Antifebrin | HMDB | N-Acetylarylamine | ChEBI |
|
---|
Chemical Formula | C8H9NO |
---|
Average Molecular Weight | 135.1632 |
---|
Monoisotopic Molecular Weight | 135.068413915 |
---|
IUPAC Name | N-phenylacetamide |
---|
Traditional Name | acetanilide |
---|
CAS Registry Number | 55576-55-1 |
---|
SMILES | CC(=O)NC1=CC=CC=C1 |
---|
InChI Identifier | InChI=1S/C8H9NO/c1-7(10)9-8-5-3-2-4-6-8/h2-6H,1H3,(H,9,10) |
---|
InChI Key | FZERHIULMFGESH-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as benzene and substituted derivatives. These are aromatic compounds containing one monocyclic ring system consisting of benzene. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Not Available |
---|
Direct Parent | Benzene and substituted derivatives |
---|
Alternative Parents | |
---|
Substituents | - Monocyclic benzene moiety
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Carboximidic acid derivative
- Carboximidic acid
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 6.39 mg/mL at 25 °C | Not Available | LogP | 1.16 | HANSCH,C ET AL. (1995) |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
N-Acetylarylamine,1TMS,isomer #1 | CC(=O)N(C1=CC=CC=C1)[Si](C)(C)C | 1305.0 | Semi standard non polar | 33892256 | N-Acetylarylamine,1TMS,isomer #1 | CC(=O)N(C1=CC=CC=C1)[Si](C)(C)C | 1380.0 | Standard non polar | 33892256 | N-Acetylarylamine,1TMS,isomer #1 | CC(=O)N(C1=CC=CC=C1)[Si](C)(C)C | 1672.9 | Standard polar | 33892256 | N-Acetylarylamine,1TBDMS,isomer #1 | CC(=O)N(C1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 1519.7 | Semi standard non polar | 33892256 | N-Acetylarylamine,1TBDMS,isomer #1 | CC(=O)N(C1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 1586.7 | Standard non polar | 33892256 | N-Acetylarylamine,1TBDMS,isomer #1 | CC(=O)N(C1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 1823.9 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - N-Acetylarylamine EI-B (Non-derivatized) | splash10-000f-9000000000-62d570000b48b0837073 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - N-Acetylarylamine GC-EI-TOF (Non-derivatized) | splash10-0006-9100000000-4122036cecde322748ea | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - N-Acetylarylamine GC-EI-TOF (Non-derivatized) | splash10-014i-0900000000-5b4e4f73d383d9139de8 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - N-Acetylarylamine GC-EI-TOF (Non-derivatized) | splash10-00dr-4900000000-2293bbd44d7f9fc8077c | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - N-Acetylarylamine EI-B (Non-derivatized) | splash10-000f-9000000000-62d570000b48b0837073 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - N-Acetylarylamine GC-EI-TOF (Non-derivatized) | splash10-0006-9100000000-4122036cecde322748ea | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - N-Acetylarylamine GC-EI-TOF (Non-derivatized) | splash10-014i-0900000000-5b4e4f73d383d9139de8 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - N-Acetylarylamine GC-EI-TOF (Non-derivatized) | splash10-00dr-4900000000-2293bbd44d7f9fc8077c | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylarylamine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-9200000000-2bd7881947c0c62f2a31 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylarylamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylarylamine LC-ESI-QQ , negative-QTOF | splash10-001i-0900000000-7eb05e193f729f0e2711 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylarylamine LC-ESI-QQ , negative-QTOF | splash10-000x-9700000000-e7d678f13a1e17c9ed99 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylarylamine LC-ESI-QQ , negative-QTOF | splash10-0006-9000000000-1d77cc60e4a023d4dd22 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylarylamine LC-ESI-QQ , negative-QTOF | splash10-0006-9000000000-8877ad97a3992f913113 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylarylamine LC-ESI-QQ , negative-QTOF | splash10-0006-9000000000-71ff77e29eb728137605 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylarylamine LC-ESI-QQ , positive-QTOF | splash10-014r-4900000000-7f8d10f07700a193e622 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylarylamine LC-ESI-QQ , positive-QTOF | splash10-014u-9300000000-f975b8216fe43fc1d9cc | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylarylamine LC-ESI-QQ , positive-QTOF | splash10-0006-9200000000-12e9d1610beecb011c9d | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylarylamine LC-ESI-QQ , positive-QTOF | splash10-004l-9200000000-2d487e012ca3b59d0a9b | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylarylamine LC-ESI-QQ , positive-QTOF | splash10-004l-9000000000-e50ad2b0e89696e08851 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylarylamine 35V, Positive-QTOF | splash10-0006-9000000000-46f47c26afc8877cc2f1 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylarylamine 10V, Positive-QTOF | splash10-000l-5900000000-61578dc3c9789feb5f8a | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylarylamine 20V, Positive-QTOF | splash10-0006-9300000000-299ec76356db162d4259 | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylarylamine 40V, Positive-QTOF | splash10-00kf-9000000000-f918e8f5428211fb9a25 | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylarylamine 10V, Negative-QTOF | splash10-001i-2900000000-9def162dfa4b1400554c | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylarylamine 20V, Negative-QTOF | splash10-0006-9500000000-137a2164ab31a3308792 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylarylamine 40V, Negative-QTOF | splash10-0006-9100000000-63a8773b99832a19d5e2 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylarylamine 10V, Negative-QTOF | splash10-0006-9400000000-753f541f128c751917c7 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylarylamine 20V, Negative-QTOF | splash10-0006-9100000000-5df9abaffe7f5bdbe5d7 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylarylamine 40V, Negative-QTOF | splash10-0006-9000000000-e621b748b2a107ee39e8 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylarylamine 10V, Positive-QTOF | splash10-000l-4900000000-b549e531b7dd15d51b67 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylarylamine 20V, Positive-QTOF | splash10-0006-9000000000-60ecfd1f5d15dfbcfb81 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylarylamine 40V, Positive-QTOF | splash10-014l-9000000000-df32423a180287f62567 | 2021-09-25 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| Not Available |
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB022512 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 880 |
---|
KEGG Compound ID | C07565 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | N-Phenylacetamide |
---|
METLIN ID | 6107 |
---|
PubChem Compound | 904 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 28884 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | M01251 |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Ogino M, Nakada Y, Negoro N, Itokawa S, Nishimura S, Sanada T, Satomi T, Kita S, Kubo K, Marui S: Discovery of a novel acyl-CoA: cholesterol acyltransferase inhibitor: the synthesis, biological evaluation, and reduced adrenal toxicity of (4-phenylcoumarin)acetanilide derivatives with a carboxylic acid moiety. Chem Pharm Bull (Tokyo). 2011;59(11):1369-75. [PubMed:22041073 ]
- Poraj-Kobielska M, Kinne M, Ullrich R, Scheibner K, Kayser G, Hammel KE, Hofrichter M: Preparation of human drug metabolites using fungal peroxygenases. Biochem Pharmacol. 2011 Oct 1;82(7):789-96. doi: 10.1016/j.bcp.2011.06.020. Epub 2011 Jun 23. [PubMed:21723855 ]
- Wu Y, Choy PY, Mao F, Kwong FY: Toluene derivatives as simple coupling precursors for cascade palladium-catalyzed oxidative C-H bond acylation of acetanilides. Chem Commun (Camb). 2013 Jan 25;49(7):689-91. doi: 10.1039/c2cc37352a. [PubMed:23230572 ]
- Yan GF, Wang Q, Wei BL, Sun XC, Chen GQ, Gao SM: [Photophysical properties of novel organic europium (III) complexes]. Guang Pu Xue Yu Guang Pu Fen Xi. 2010 Oct;30(10):2606-10. [PubMed:21137382 ]
- Chen CZ, Yan CT, Kumar PV, Huang JW, Jen JF: Determination of alachlor and its metabolite 2,6-diethylaniline in microbial culture medium using online microdialysis enriched-sampling coupled to high-performance liquid chromatography. J Agric Food Chem. 2011 Aug 10;59(15):8078-85. doi: 10.1021/jf201129j. Epub 2011 Jul 11. [PubMed:21707080 ]
- Liang HQ, Tao YP, Han LG, Han YX, Mo YJ: [Raman, FTIR spectra and normal mode analysis of acetanilide]. Guang Pu Xue Yu Guang Pu Fen Xi. 2012 Oct;32(10):2706-9. [PubMed:23285870 ]
- Sun L, Zhang S, Song Q: (4-Chloro-acetanilido-kappa(2)N,O)bis-[2-(pyridin-2-yl)phenyl-kappa(2)C(1),N]irid ium(III). Acta Crystallogr Sect E Struct Rep Online. 2013 Feb 1;69(Pt 2):m98. doi: 10.1107/S1600536813000433. Epub 2013 Jan 12. [PubMed:23424440 ]
- Bouchonnet S, Bourcier S, Souissi Y, Genty C, Sablier M, Roche P, Boireau V, Ingrand V: GC-MS(n) and LC-MS/MS couplings for the identification of degradation products resulting from the ozonation treatment of Acetochlor. J Mass Spectrom. 2012 Apr;47(4):439-52. doi: 10.1002/jms.2056. [PubMed:22689619 ]
- Kalkhoff SJ, Vecchia AV, Capel PD, Meyer MT: Eleven-year trend in acetanilide pesticide degradates in the Iowa River, Iowa. J Environ Qual. 2012 Sep-Oct;41(5):1566-79. doi: 10.2134/jeq2011.0426. [PubMed:23099949 ]
- Weiler M, Nakamura T, Sekiya H, Dopfer O, Miyazaki M, Fujii M: Ionization-induced solvent migration in acetanilide-methanol clusters inferred from isomer-selective infrared spectroscopy. Chemphyschem. 2012 Dec 7;13(17):3875-81. doi: 10.1002/cphc.201200704. Epub 2012 Oct 30. [PubMed:23112069 ]
- Fu YY, Yang CX, Yan XP: Metal-organic framework MIL-100(Fe) as the stationary phase for both normal-phase and reverse-phase high performance liquid chromatography. J Chromatogr A. 2013 Jan 25;1274:137-44. doi: 10.1016/j.chroma.2012.12.015. Epub 2012 Dec 17. [PubMed:23290359 ]
- Ogino M, Fukui S, Nakada Y, Tokunoh R, Itokawa S, Kakoi Y, Nishimura S, Sanada T, Fuse H, Kubo K, Wada T, Marui S: Discovery of a potent and orally available acyl-CoA: cholesterol acyltransferase inhibitor as an anti-atherosclerotic agent: (4-phenylcoumarin)acetanilide derivatives. Chem Pharm Bull (Tokyo). 2011;59(10):1268-73. [PubMed:21963637 ]
- Lu C, Markina NA, Larock RC: Synthesis of N-acylcarbazoles through palladium-catalyzed aryne annulation of 2-haloacetanilides. J Org Chem. 2012 Dec 21;77(24):11153-60. doi: 10.1021/jo3021727. Epub 2012 Dec 5. [PubMed:23214463 ]
|
---|